The table below shows Adaptive Biotechnologies Corp's cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Operating cash flow
-$9.54M
-$28.48M
-$38.35M
-$59.15M
-$64.45M
-$58.24M
Capital expenditure
$796.00K
$1.26M
$1.51M
$2.92M
$3.08M
$15.84M
Investing cash flow
$9.14M
$25.57M
$44.51M
$62.98M
$37.69M
$93.82M
Dividends paid
-
-
-
-
-
ADPT operating cash flow (10-K history)
Adaptive Biotechnologies Corp reported operating cash flow of -$45.99M for fiscal year 2025. That is up 51.7% from -$95.21M in fiscal 2024. Over the 9 fiscal years shown, operating cash flow declined from -$34.86M (FY 2017) to -$45.99M. Figures come from the company's audited annual reports as filed with the SEC.
